Holoeyes Interview: Dr. Michele DIANA & Dr. Maki Sugimoto at iSMIT2023 in IRCAD Taiwan. Oct 20, 2023
Interview: Prof. Michele DIANA MD & Prof. Maki Sugimoto MD at iSMIT2023 in IRCAD Taiwan. Oct 20, 2023
Prof. Michele DIANA MD, PhD, MBA, Surgery, University Hospital of Strasbourg, IRCAD France Prof. Maki Sugimoto MD, PhD, Innovation Lab, Teikyo University Okinaga Research Institute, Surgery, Teikyo University Hospital. Transcript: Ladies and gentlemen, I have had the privilege of knowing Maki Sugimoto for a long time. And I have to say we have something in common with this guy. We both try to augment the surgical eye towards surgical precision. I was telling him that I had seen some presentations in which they were talking about Horiz, and he asked me, "How is this even possible? I did not export the concept outside of Japan." First of all, this is not true. He is very humble because he is disseminating. He attends regularly international conferences. We probably met for the first time in Miami, I don't remember. He is disseminating and clearly, this is a great idea. It will bring the gaze in the direct gaze of the surgeon, to the augmented information. This is something that attracts, fascinates, and is immediately perceived as value-adding. When we do great things, people talk about us much more than we know. We may ignore how much buzz we're making around us, particularly when like Maki, we are concentrated and focused on continuously improving, aiming towards excellence. Being humble is correct, but being aware of one's own strength is very, very important. You're doing a great job. =What is the benefit of our Holoeyes system for surgeons? As per other competitors like Holoeyes, the augmentation of the view is straightforward. We have published something academic on this. The first level of augmentation is seen by transparency. You're converting a three-dimensional image that can be obtained with a CT scan, or an MRI, into something that becomes more logical and visible to the human eye, and you can overlay it and see through. Seeing by transparency is like a superhero power. Then you have technologies like surgical optical imaging, fluorescent, hyperspectral, and multispectral. They do not go through the body, they allow a 1cm, maximum 2cm depth of penetration, but they reveal the invisible. And then there is a third level of augmentation, which is seeing the microscopic in real-time. Endoc-focal microscopy, optical coherence tomography, holography in real-time with digital means. So, three levels of augmentation: see by transparency, see the invisible in real-time, and see the microscopic in real-time. That's augmenting the surgical eye towards precision. This morning other surgeons are having a presentation about Holoeyes. I saw not a surgeon but a chemist developing new molecules. And he was displaying something in the operating room. The field is crowded, and there is a lot of competition, so you need to pick up your fair share of value in a very strategic way. But the product is there, the talent is there, so I'm positive. =We are now applying to get the CE mark in Europe by our company. After getting the CE mark, we want to introduce you to the newest version of Holoeyes. Shortly, we want to collaborate. You have my contacts. Thank you.
要約
Maki Sugimoto先生とは長いお付き合いがあり、お互いが外科手術の精度向上に努めています。Maki 博士は国際的な影響を持ちながらも非常に謙虚で、その貢献を過小評価していることがあります。Maki 博士が関与する「Holoeyes」システムは、視野の拡張について3つのレベルがあります。まず、3次元の医療画像を透過して見やすくできます。次に、特別な光学的イメージング技術を用いて、体内の1-2cm程度の深さまで視認できるようにします。そして最後に、微細な部分をリアルタイムで見ることができます。これらの特徴によって、外科手術の精度は向上します。 今朝もHoloeyesに関する他者の発表があり、新しい分子の開発も行われていることがわかりました。この分野は競争が激しいですが、確かな製品技術が存在しているので私は導入に前向きです。新しいバージョンのHoloeyesを紹介できれば, 欧州でもすぐにコラボレーションしたいので連携しましょう。ありがとう。